Inventor · disambiguated record
Simon Yau
Also filed as: YAU SIMON · YAU SIMON K · YAU SIMON KWOK-PAN
5 granted patents·4 pending applications·28 citations·filing 2006–2023
79Inventor score
Top patents by PatentIndex Score
9 records- 0195US11724986B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2020·Granted Aug 15, 2023·6 cites·4 claims
- 0294US10851061B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2019·Granted Dec 1, 2020·8 cites·8 claims
- 0392US11760726B2Crystalline solid forms of N-{4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl} -n'-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2021·Granted Sep 19, 2023·2 cites·11 claims
- 0492US10501418B2Crystalline solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2015·Granted Dec 10, 2019·12 cites·11 claims
- 0581US12486233B2Crystalline Solid forms of N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N′-(4-fluorophenyl) cyclopropane-1,1-dicarboxamide, processes for making, and methods of useEXELIXIS INC·Filed 2023·Granted Dec 2, 2025·0 cites·11 claims
- 0656US2007148237A1Sustained-release formulation of zonisamideOREXIGEN THERAPEUTICS INC·Filed 2006·Application pending·0 cites
- 0755US2014080857A1Methods for prophylatic appetite suppressionOREXIGEN THERAPEUTICS INC·Filed 2013·Application pending·0 cites
- 0848US2016354348A1Methods for prophylatic appetite suppressionOREXIGEN THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 0933US2011039799A1A1 adenosine receptor agonist polymorphsGILEAD PALO ALTO INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Simon Yau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →